Osaic Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,018
| Closed | -$12.2K | – | 7824 |
|
|
2024
Q4 | $12.2K | Sell |
4,018
-37
| -0.9% | -$161 | ﹤0.01% | 5658 |
|
|
2024
Q3 | $21K | Buy |
4,055
+641
| +19% | +$3.19K | ﹤0.01% | 5361 |
|
|
2024
Q2 | $8.77K | Buy |
3,414
+679
| +25% | +$2.32K | ﹤0.01% | 5857 |
|
|
2024
Q1 | $13.5K | Sell |
2,735
-908
| -25% | -$5.38K | ﹤0.01% | 5584 |
|
|
2023
Q4 | $32.1K | Sell |
3,643
-890
| -20% | -$7.29K | ﹤0.01% | 5192 |
|
|
2023
Q3 | $52K | Buy |
4,533
+402
| +10% | +$7.73K | ﹤0.01% | 4979 |
|
|
2023
Q2 | $105K | Buy |
4,131
+433
| +12% | +$13.5K | ﹤0.01% | 4401 |
|
|
2023
Q1 | $119K | Buy |
3,698
+98
| +3% | +$3.06K | ﹤0.01% | 4299 |
|
|
2022
Q4 | $65.7K | Buy |
3,600
+276
| +8% | +$6.31K | ﹤0.01% | 4739 |
|
|
2022
Q3 | $90K | Buy |
3,324
+486
| +17% | +$9.86K | ﹤0.01% | 4470 |
|
|
2022
Q2 | $39K | Hold |
2,838
| – | – | ﹤0.01% | 5144 |
|
|
2022
Q1 | $56K | Buy |
2,838
+1,071
| +61% | +$16.2K | ﹤0.01% | 5019 |
|
|
2021
Q4 | $29K | Sell |
1,767
-415
| -19% | -$6.92K | ﹤0.01% | 5534 |
|
|
2021
Q3 | $60K | Sell |
2,182
-34
| -2% | -$970 | ﹤0.01% | 4968 |
|
|
2021
Q2 | $65K | Buy |
2,216
+241
| +12% | +$6.95K | ﹤0.01% | 4842 |
|
|
2021
Q1 | $55K | Sell |
1,975
-82
| -4% | -$2.27K | ﹤0.01% | 4824 |
|
|
2020
Q4 | $58K | Sell |
2,057
-305
| -13% | -$7.9K | ﹤0.01% | 4460 |
|
|
2020
Q3 | $59K | Buy |
2,362
+747
| +46% | +$19.6K | ﹤0.01% | 4189 |
|
|
2020
Q2 | $39K | Sell |
1,615
-804
| -33% | -$15.9K | ﹤0.01% | 4375 |
|
|
2020
Q1 | $37K | Buy |
+2,419
| New | +$50K | ﹤0.01% | 4223 |
|
Other funds holding RVNC
Osaic Holdings's RVNC Position: Q1 2025 in Review
Osaic Holdings sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 4,018 shares — an estimated $12.2K sold.
Osaic Holdings first reported a position in RVNC in Q1 2020 and held it in 20 quarters. The position peaked at $119K in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Osaic Holdings reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Osaic Holdings sold 4,018 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $12.2K.
- Osaic Holdings first reported a position in Revance Therapeutics, Inc. in Q1 2020 and held it in 20 quarters.
- Osaic Holdings's Revance Therapeutics, Inc. position peaked at $119K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.